be devastating to the prospects of such company, which in turn could negatively affect the performance of the Fund. Dependence on Reimbursement and Third-Party Pricing Policies for Products The ability of the Fund’s portfolio companies to commercialize any product candidate successfully also will depend in part on the extent to which re